Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis
DenmarkStudy on Batoclimab for Treating Patients with Active Thyroid Eye Disease
GermanyStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
AustriaStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib
AustriaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
CroatiaSafety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia
BulgariaStudy on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
CzechiaStudy on Low-Dose Aldesleukin and Ciclosporin for Patients with Newly Diagnosed Type 1 Diabetes Retaining Insulin Secretion
FranceStudy on Methotrexate and Phototherapy for Adults with Progressive Vitiligo
FranceStudy on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis
CzechiaStudy on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
